Finance

Lists
MOLBIO:NSE
Molbio Diagnostics Limited
₹1,117.00
-2.37%
(-27.15) 1D
Aug 28, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MOLBIO...
Open
₹1,153.95
High
₹1,156.10
Low
₹1,077.50
Mkt. cap
126.33B
Avg. vol.
0.00
Volume
980.90K
P/E ratio
75.60
52-wk high
₹1,264.60
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Open
₹1,153.95
High
₹1,156.10
Low
₹1,077.50
Mkt. cap
126.33B
Avg. vol.
0.00
Volume
980.90K
P/E ratio
75.60
52-wk high
₹1,264.60
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis. The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries. In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited
CEO-
Employees1.22K
Founded2000
Headquarters-
SectorMedical device
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps